#infection_and_vaccine_immunity - Biweekly newsletter of the International Cytokine & Interferon Society

Boosting human immunology: harnessing the potential of immune organoids

July 14, 2025

Featured on the March 12, 2025 cover of EMBO Molecular Medicine, this recent publication, by Maximilian Moll and Prof. Dr. Dirk Baumjohann of the Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology at University Hospital Bonn titled, “Boosting human immunology: harnessing the potential of immune organoids” highlights scientific advances [READ MORE]

Going for Gold: The Olympic Spirit of Cytokine Science

March 1, 2026

The Winter Olympics brought a much-needed mental break during a February- the middle of Northwestern’s Winter Quarter, a respite from undergraduate teaching, grant writing, and the pandemonium of ongoing political noise. The beauty of the snowy Milan-Cortino mountains of was a perfect backdrop to the gathering of outstanding athletes from [READ MORE]

Photo of Anna Dittrich on a cold, windy beach

From Düsseldorf to Tokyo — and Back to IL-6: Meet Anna Dittrich

March 1, 2026

I´m a biologist by training and currently work as a senior researcher at the Otto von Guericke University Magdeburg, Germany. My research focuses on understanding how intracellular cytokine-induced signaling robustly encodes and transmits information, with a special focus on my favorite cytokine IL-6. Please tell us your name, degree, where [READ MORE]

Concentrations of Pro-inflammatory and Anti-inflammatory Cytokines and Metallopeptidases in the Serum During the Treatment of Pain Caused by Bulging of the Intervertebral Disc in the Lumbar Spine

March 1, 2026

Concentrations of Pro-inflammatory and Anti-inflammatory Cytokines and Metallopeptidases in the Serum During the Treatment of Pain Caused by Bulging of the Intervertebral Disc in the Lumbar Spine ClinicalTrials.gov ID NCT06545812 Sponsor: Josip Juraj Strossmayer, University of Osijek Information provided: by Karla Rožac, Josip Juraj Strossmayer, University of Osijek (Responsible Party) [READ MORE]

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia

March 1, 2026

A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 Lymphopenia ClinicalTrials.gov ID NCT05600920 Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Information provided by: National Institutes of Health Clinical Center (CC) (National Institute of Allergy and Infectious Diseases (NIAID)) (Responsible Party) Last Update [READ MORE]

Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)

March 1, 2026

Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23) ClinicalTrials.gov ID NCT06792487 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Information provided by: Fondazione Policlinico Universitario Agostino Gemelli IRCCS (Responsible Party) Last Update Posted: 2025-01-24 Brief Summary Psoriasis is an immune-mediated inflammatory skin disease characterized by the presence [READ MORE]

Share this: